Table 1.
Patient demographics characteristics of whom were referred to the on-site treatment program.
| Patient demographics | Number of patients referred to HCV treatment program, n (%) |
|---|---|
| Gender | |
| Female | 35 (18.4) |
| Male | 155 (81.6) |
| Race | |
| African American | 127 (66.8) |
| White/Caucasian | 37 (19.5) |
| Asian | 2 (1.1) |
| Declined to respond | 24 (12.6) |
| Ethnicity | |
| Hispanic or Latino | 25 (13.2) |
| Non-Hispanic or Latino | 158 (83.2) |
| Undefined | 7 (3.6) |
| Age | |
| 18-39 | 12 (6.3) |
| 40-59 | 112 (58.9) |
| >60 | 66 (34.7) |
| Insurance | |
| Medicaid | 151 (79.5) |
| Medicare | 28 (14.7) |
| Private | 11 (5.8) |
| Mental health diagnosis | |
| Bipolar | 26 (13.7) |
| Schizophrenia | 14 (7.4) |
| Depression/mood disorder | 110 (57.9) |
| Anxiety | 70 (36.8) |
| Adjustment disorder | 12 (6.3) |
| PTSD | 14 (7.4) |
| Other (insomnia and panic disorder) | 34 (17.9) |
| HCV risk factor | |
| Baby boomer (1945-1965) | 146 (76.8) |
| History of IVDU | 105 (55.3) |
| Unknown history of IVDU | 40 (21) |
| Homelessness | 68 (35.8) |
| Unlicensed tattoo | 3 (1.6) |
| Incarceration | 31 (16.3) |
| HCV positive partner | 2 (1.1) |
| Co-infection | |
| HIV | 65 (34.2) |
| HBV | 3 (1.6) |
| HCV mono-infected | 122 (64.2) |
| Drug use history | |
| Heroin | 69 (36.3) |
| Cocaine | 72 (37.9) |
| Crack cocaine | 35 (18.4) |
| Marijuana | 28 (14.7) |
| Other (methadone, amphetamines, and so on) | 30 (15.8) |
| Genotype | |
| 1a | 130 (68.4) |
| 1b | 30 (15.8) |
| 2 | 14 (7.4) |
| 3 | 15 (7.9) |
| 4 | 1 (0.5) |
| Fibrosis Score | |
| F0 | 17 (8.9) |
| F0-F1 | 14 (7.4) |
| F1 | 5 (2.6) |
| F1-F2 | 35 (18.4) |
| F2 | 16 (8.4) |
| F2-F4 | 13 (6.8) |
| F3 | 32 (16.8) |
| F3-F4 | 7 (3.7) |
| F4 | 51 (26.8) |
| Treatment length | |
| 8 weeks | 14 (9.9) |
| 12 weeks | 116 (81.7) |
| 24 weeks | 12 (8.4) |
| Treatment experienceda | 36 (18.9) |
| Treatment naiveb | 154 (81.1) |
Abbreviations: HCV, hepatitis C virus; HBV, hepatitis B virus; PTSD, post-traumatic stress disorder; IVDU, intravenous drug use.
a
Previously had been treated for hepatitis C.
b
Never received treatment for hepatitis C.